White House requires federally funded labs to buy DNA only from screened, certified suppliers
The National Policy for Nucleic Acid Synthesis Screening replaces self-attestation with verified screening of orders of 50 or more nucleotides and of benchtop synthesisers, and cites risks including uplift from superintelligence (SI); it covers federally funded research only.
Why it matters
Gene synthesis screening is one of the main safeguards against AI-assisted bioweapon development, and this policy replaces the 2024 framework's reliance on self-attestation with independent verification and NIST standards. It is the first US policy text to frame the risk explicitly around uplift from superintelligence, and it extends screening to benchtop synthesisers, which can work outside central providers. Its reach is limited to recipients of federal life-sciences funding; watch NIST's standards within 90 days, HHS's first supplier list within 160 days, and whether Congress extends screening to everyone else.
Key facts
- Memorandum NSTM-6 dated November 5, 2026
- Signed by Marco Rubio and Michael Kratsios
- Orders of 50 or more nucleotides must be screened
- NIST standards within 90 days; HHS supplier list within 160 days
- Certified nucleic acids within 250 days; benchtop equipment within 340 days
- Replaces the 2024 Framework for Nucleic Acid Synthesis Screening